| ★ | Lifestyle, Pharmacologic Therapies, and EXCEL Trial Data Reshape MASLD Treatment Framework | | 48 | Estados Unidos | |
| 18 | Beyond Atherosclerosis: Coronary Calcium Scoring in Dyslipidemia, CKM Syndrome | | 2.0K | Estados Unidos | 64 |
| 12 | Inhaled Treprostinil for IPF: TETON-1 Phase 3 Results With Steven Nathan, MD | ATS 2026 | | 301 | Estados Unidos | 66 |
| 6 | Mixed AERIFY Data May Delay Itepekimab Approval Pathway in COPD, With Klaus F. Rabe, MD, PhD | | 198 | Estados Unidos | 67 |
| 9 | Highlighting FDA-Approved Therapies in Atopic Dermatitis, With Chris Bunick, MD, PhD | | 152 | Estados Unidos | 66 |
| 1 | FIND-CKD Expands Finerenone Evidence Beyond Diabetic CKD, With Rajiv Agarwal, MD | | 131 | Estados Unidos | 70 |
| 15 | AERIFY: Phase 3 Data Reveal Challenges, Potential of Itepekimab in COPD | | 105 | Estados Unidos | 65 |
| 17 | VESALIUS-CV: Evolocumab Prevents Cardiovascular Disease in High-Risk Diabetes | | 96 | Estados Unidos | 65 |
| 11 | Improving GLP-1 Adherence in Patients With Diabetes, With Vivian Fonseca, MD | | 91 | Estados Unidos | 66 |
| 7 | SYMPHONY-PE: Early Thrombectomy Improves Pulmonary Embolism Outcomes | | 86 | Estados Unidos | 67 |
| 4 | Looking Beyond ALP Response in PBC With Saroglitazar, With Raj Vuppalanchi, MD | | 68 | Estados Unidos | 67 |
| 19 | Tezepelumab Cuts Severe Asthma Exacerbations 70% in Real-World Patients | ATS 2026 | | 68 | Estados Unidos | 64 |
| 3 | Omalizumab vs Oral Immunotherapy for Multifood Allergy | | 65 | Estados Unidos | 68 |
| 5 | GLP-1 Discontinuation in Type 2 Diabetes: What Happens When Patients Stop? | | 64 | Estados Unidos | 67 |
| 16 | ADorable-1 Results: Key Findings in Pediatric Atopic Dermatitis | | 58 | Estados Unidos | 65 |
| 10 | SGLT2 Inhibitors May Reduce COPD Readmissions I ATS 2026 | | 48 | Estados Unidos | 66 |
| 13 | FMD Peak Systolic Velocity May Lead to Comprehensive Clinical Guidelines | | 33 | Estados Unidos | 66 |
| 20 | Diagnosing Non-IgE Food Hypersensitivity | Brian Lacy, MD, PhD | EAC 2026 | | 31 | Estados Unidos | 64 |
| 14 | Does Insulin Resistance Harm the Lungs? CT Data Offers New Clues | ATS 2026 | | 25 | Estados Unidos | 66 |
| 2 | Key Non-Medication Clinical Pearls for Dermatologists, With Matthew Zirwas, MD | | 21 | Estados Unidos | 70 |
| 8 | Abdominal Pain and Bloating: Recognizing HAE, MCAS, and Eosinophilic GI Disorders | Brian Lacy, MD | | 20 | Estados Unidos | 66 |